BAIN CAPITAL INVESTORS LLC Long-Term Concentrated

CIK: 0001040508 · Show all filings

Period: Q1 2024 (← Previous) (Next →)

Filing Date: May 15, 2024

Total Value ($000): $4,481,902 (100.0% shares, 0.0% debt)

Holdings (4)

— CEREVEL THERAPEUTICS HLDNG I 61.9%

Value ($000) $2,776,284 Shares 65,679,781 Est. Cost $18.73 Unrealized —

SGRY SURGERY PARTNERS INC 33.2%

Value ($000) $1,489,918 Shares 49,946,972 Est. Cost $31.75 Unrealized -1.5%

AVAH AVEANNA HEALTHCARE HLDGS INC 4.5%

Value ($000) $203,186 Shares 81,600,880 Est. Cost $11.86 Unrealized -79.7%

ADV ADVANTAGE SOLUTIONS INC 0.3%

Value ($000) $12,514 Shares 2,890,000 Est. Cost $10.52 Unrealized -62.6%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	CEREVEL THERAPEUTICS HLDNG I	65,679,781	$2,776,284	61.9%	$18.73	—	COM	15678U128
SGRY	SURGERY PARTNERS INC	49,946,972	$1,489,918	33.2%	$31.75	-1.5%	COM	86881A100
AVAH	AVEANNA HEALTHCARE HLDGS INC	81,600,880	$203,186	4.5%	$11.86	-79.7%	COM	05356F105
ADV	ADVANTAGE SOLUTIONS INC	2,890,000	$12,514	0.3%	$10.52	-62.6%	COM CL A	00791N102